Abbott Labs (ABT) PT Lowered to $125 at Barclays
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $116.64 +2.19%
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays analyst Travis Steed lowered the price target on Abbott Labs (NYSE: ABT) to $125.00 (from $150.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Abbott Labs (ABT) PT Raised to $135 at TD Cowen
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
- Kuaishou Technology (1024:HK) PT Lowered to HK$27.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
